Reynders Mc Veigh Capital Management, LLC Crispr Therapeutics Ag Transaction History
Reynders Mc Veigh Capital Management, LLC
- $1.74 Billion
- Q1 2024
A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 96,979 shares of CRSP stock, worth $5.15 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
96,979
Previous 92,048
5.36%
Holding current value
$5.15 Million
Previous $5.76 Million
14.73%
% of portfolio
0.38%
Previous 0.36%
Shares
14 transactions
Others Institutions Holding CRSP
# of Institutions
550Shares Held
56.3MCall Options Held
2.91MPut Options Held
2.47M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.16MShares$433 Million3.97% of portfolio
-
Capital International Investors Los Angeles, CA7.84MShares$416 Million0.11% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.27MShares$174 Million0.16% of portfolio
-
Nikko Asset Management Americas, Inc.3.27MShares$174 Million2.23% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.7MShares$144 Million0.11% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.14B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....